Log In
BCIQ
Print this Print this
 

tramadol-acetaminophen (DDS-06C)

  Manage Alerts
Collapse Summary General Information
Company Endo International plc
DescriptionTramadol and acetaminophen combination tablet formulated using Contramid controlled-release technology
Molecular Target Mu opioid receptor (MOR) (OPRM1) ; Monoamine transporters
Mechanism of ActionMonoamine reuptake inhibitor; Mu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentApproved
Standard IndicationPain
Indication DetailsTreat lower back pain; Treat moderate to severe pain
Regulatory Designation
PartnerGruenenthal Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$7.2M

0

$7.2M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

10/25/2010

$7.2M

0

$7.2M

Get a free BioCentury trial today